Tag Archives: cowin app

The next phase of the world’s largest Covid-19 vaccination campaign for age-appropriate population groups began on March 1. Registration opened at 9am on Monday and citizens will be able to register, book an appointment for vaccination, anytime, anywhere, using the Co-WIN platform. A user guide for citizen registration and vaccination …

The Co-WIN portal allows eligible citizens (seniors and those over 45 who have comorbidities) to register and get an appointment for vaccination. Registration for the second phase of the COVID-19 vaccination campaign across India started on Monday March 1 and the Union government has opened registrations for the same on …

As India prepares for the next phase of the Covid-19 vaccination campaign for people over 60 years old and those over 45 years old with comorbidities, starting tomorrow, March 1, 2021, the registration of the vaccine on the Co -Win will open tomorrow at 9:00 am. You can access the …

Two Covid-19 vaccines have been approved by the General Drug Enforcement of India (DCGI) for restricted emergency use. Serum Institute of India and Bharat Biotech are ready to supply vaccines for the first phase of vaccination, which will include frontline workers followed by people over 50 years of age. To …

India has approved two COVID-19 vaccines – Covishield ‘from the Serum Institute of India and’ Covaxin ‘from Bharat Biotech – for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines should be given in two doses and should be stored at 2-8 ° C. Also read: Why people …

One day after Samajwadi Party chief Akhilesh Yadav questioned India’s Covid-19 vaccines and said he would not take “the BJP vaccine,” Congressional leaders Jairam Ramesh, Shashi Tharoor also doubted approval. awarded to the Bharat Biotech vaccine while in its third phase of testing. . Criticizing their doubts, Union Minister Hardeep …

After the Controller General of Drugs of India (DCGI) gave the green signal on Sunday to two candidate vaccines for restricted and emergency use, Union Minister Rajnath Singh praised Prime Minister Narendra Modi’s vision for Aatmanirbhar Bharat, who said that he has greatly helped India to come. with indigenous solutions …

With Covishield and Covaxin obtaining approval from the Drug Control General of India (DCGI) for emergency restricted use, the vaccination campaign is now just a matter of announcement, as both the Serum Institute of India and Bharat Biotech are prepared to supply the doses. required for phase one vaccine. In …

For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …